Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

URMEEL HASMUKH PATEL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1013263110
CMS profile
534521
Location
SHENANDOAH, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$3,616.69

189 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,402.06 184
Education $214.63 5

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $340.26 15
Janssen Biotech, Inc. $264.75 16
Seagen Inc. $202.07 8
AstraZeneca Pharmaceuticals LP $194.28 12
GENZYME CORPORATION $193.82 9
GlaxoSmithKline, LLC. $193.49 8
Incyte Corporation $177.14 10
Novartis Pharmaceuticals Corporation $174.71 11
Daiichi Sankyo Inc. $156.00 7
Bayer HealthCare Pharmaceuticals Inc. $113.33 6
E.R. Squibb & Sons, L.L.C. $103.03 6
Merck Sharp & Dohme Corporation $97.62 5
Astellas Pharma US Inc $96.55 6
Celgene Corporation $96.38 5
Takeda Pharmaceuticals U.S.A., Inc. $84.80 3
Lilly USA, LLC $73.11 4
Gilead Sciences, Inc. $67.43 4
Ipsen Biopharmaceuticals, Inc $66.32 3
BeiGene USA, Inc. $57.87 3
Dova Pharmaceuticals $54.60 3
Taiho Oncology, Inc. $54.13 3
Boehringer Ingelheim Pharmaceuticals, Inc. $54.03 4
Myovant Sciences Inc. $50.22 2
PFIZER INC. $43.19 2
Myriad Genetic Laboratories, Inc. $38.75 2
Eisai Inc. $37.75 2
Janssen Pharmaceuticals, Inc $33.73 2
Acrotech Biopharma LLC $33.71 2
Pharmacosmos Therapeutics Inc. $33.56 2
AMAG Pharmaceuticals, Inc. $31.75 2
Regeneron Healthcare Solutions, Inc. $31.37 2
MorphoSys, US Inc. $31.00 2
Alexion Pharmaceuticals, Inc. $29.15 2
Blue Earth Diagnostics Limited $27.06 1
TOLMAR Pharmaceuticals, Inc. $25.14 1
Deciphera Pharmaceuticals Inc. $23.53 1
Genentech USA, Inc. $22.47 1
JAZZ PHARMACEUTICALS INC. $22.27 1
AbbVie Inc. $22.17 1
Nestle HealthCare Nutrition Inc. $21.21 1
Pharmacyclics LLC, An AbbVie Company $20.17 1
Servier Pharmaceuticals LLC $18.63 1
Rigel Pharmaceuticals, Inc. $18.23 1
Karyopharm Therapeutics Inc. $15.76 1
Aveo Pharmaceuticals, Inc. $15.28 1
Alnylam Pharmaceuticals Inc. $14.49 1
Adaptive Biotechnologies Corporation $14.12 1
Epizyme, Inc., $13.88 1
Exelixis Inc. $12.38 1

Page 4 of 4; records 151–189 of 189 matching records. This page contains 39 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

URMEEL HASMUKH PATEL

NPI 1013263110 · CMS profile ID 534521

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

SHENANDOAH, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–189 of 189 matching records. This page contains 39 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1013263110?year=2021&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
URMEEL HASMUKH PATEL, NPI 1013263110, CMS profile ID 534521. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–189 of 189 matching records. This page contains 39 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1013263110?year=2021&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). URMEEL HASMUKH PATEL, NPI 1013263110, CMS profile ID 534521. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–189 of 189 matching records. This page contains 39 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1013263110?year=2021&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
URMEEL HASMUKH PATEL, NPI 1013263110, CMS profile ID 534521, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–189 of 189 matching records. This page contains 39 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1013263110?year=2021&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

189 matching records · $3,616.69 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 189 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–189 of 189.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $13.5704/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783571919 CMS
Gilead Sciences, Inc. $16.5004/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848256247 CMS
Janssen Biotech, Inc. $24.7804/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788934081 CMS
Myovant Sciences Inc. $23.6104/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834979549 CMS
Amgen Inc. $19.0904/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825849641 CMS
Novartis Pharmaceuticals Corporation $18.0004/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813152299 CMS
Gilead Sciences, Inc. $19.9904/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848256245 CMS
Novartis Pharmaceuticals Corporation $18.0304/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813152295 CMS
Exelixis Inc. $12.3804/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838867915 CMS
Incyte Corporation $19.4604/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835568017 CMS
Amgen Inc. $24.7103/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826450095 CMS
Janssen Pharmaceuticals, Inc $15.0703/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788934113 CMS
Taiho Oncology, Inc. $16.9003/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843379533 CMS
Alnylam Pharmaceuticals Inc. $14.4903/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 828520495 CMS
Incyte Corporation $15.5503/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835568021 CMS
Ipsen Biopharmaceuticals, Inc $19.5903/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841906975 CMS
AMAG Pharmaceuticals, Inc. $18.9203/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 847687041 CMS
Celgene Corporation $21.1503/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783710345 CMS
Merck Sharp & Dohme Corporation $22.7703/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848729161 CMS
Incyte Corporation $22.7003/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835568019 CMS
Astellas Pharma US Inc $23.3003/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821487557 CMS
Astellas Pharma US Inc $12.6603/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821487551 CMS
Taiho Oncology, Inc. $16.7603/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843379513 CMS
E.R. Squibb & Sons, L.L.C. $12.2602/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783571897 CMS
Acrotech Biopharma LLC $21.7402/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855381739 CMS
Acrotech Biopharma LLC $11.9702/23/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855381743 CMS
Incyte Corporation $19.7102/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835568001 CMS
Myriad Genetic Laboratories, Inc. $20.7802/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834568977 CMS
Janssen Biotech, Inc. $21.4002/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788934087 CMS
Amgen Inc. $24.5702/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826450089 CMS
Amgen Inc. $17.4501/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825849657 CMS
Daiichi Sankyo Inc. $24.1001/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836245005 CMS
Astellas Pharma US Inc $22.4301/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821487545 CMS
AstraZeneca Pharmaceuticals LP $15.8301/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830102915 CMS
Janssen Biotech, Inc. $13.8001/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788934107 CMS
Karyopharm Therapeutics Inc. $15.7601/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845789377 CMS
Epizyme, Inc., $13.8801/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832342303 CMS
Daiichi Sankyo Inc. $25.7401/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836245001 CMS
Astellas Pharma US Inc $13.0201/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821487539 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,989.58 78
PY2020 $1,635.84 91
PY2021 $3,616.69 189
PY2022 $4,947.32 249
PY2023 $18,956.92 334
PY2024 $20,409.47 292
PY2025 $13,641.48 247

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $35,797.59 2
PY2024 Principal investigator $76,129.42 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

2 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $1,107.99 08/31/2025 Non-covered Recipient Entity
Millennium Research & Clinical Development
A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants with EGFR-mutated, Advanced Non-squamous Non-small Cell Lung Cancer NSCLC Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors No dispute reported 06/30/2026 1232923542
Principal investigator 1 Merck Sharp & Dohme LLC $34,689.60 08/31/2025 Non-covered Recipient Entity
Millennium Research & Clinical Development
A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB N2 NSCLC not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy Follow No dispute reported 06/30/2026 1232924254